🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6936720

Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zon

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6930186

Process for the preparation of paroxetine substantially free of alkoxy impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6909004

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6881420

Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6861426

Crystal forms of lamotrigine and processes for their preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6861553

Process for preparing nateglinide and intermediates thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6858652

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849737

Synthesis and purification of valacyclovir

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849120

Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849736

Crystalline forms of valacyclovir hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6806373

Process for preparing leflunomide form I

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6800759

Racemization and enantiomer separation of clopidogrel

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 05 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6774230

Methods for the preparation of mirtazapine intermediates

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6764997

Stabilized azithromycin compositions

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750341

Preparation of risperidone

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6737411

Racemization and enantiomer separation of clopidogrel

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723855

Method for synthesizing leflunomide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6710184

Crystalline solids of carvedilol and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6703424

Dispersible compositions containing L-DOPA ethyl ester

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6699997

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696600

L-DOPA ethyl ester salts and uses thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696601

Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689384

Stable pergolide mesylate and process for making same

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6670478

Process for preparing torsemide intermediate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired